DK169566B1 - Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet - Google Patents
Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet Download PDFInfo
- Publication number
- DK169566B1 DK169566B1 DK037589A DK37589A DK169566B1 DK 169566 B1 DK169566 B1 DK 169566B1 DK 037589 A DK037589 A DK 037589A DK 37589 A DK37589 A DK 37589A DK 169566 B1 DK169566 B1 DK 169566B1
- Authority
- DK
- Denmark
- Prior art keywords
- composition according
- composition
- methylthio
- benzoyl
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14980388A | 1988-01-29 | 1988-01-29 | |
US14980388 | 1988-01-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK37589D0 DK37589D0 (da) | 1989-01-27 |
DK37589A DK37589A (da) | 1989-07-30 |
DK169566B1 true DK169566B1 (da) | 1994-12-05 |
Family
ID=22531858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK037589A DK169566B1 (da) | 1988-01-29 | 1989-01-27 | Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0326103B1 (hu) |
JP (1) | JPH01226817A (hu) |
KR (1) | KR890011594A (hu) |
CN (1) | CN1035242A (hu) |
AR (1) | AR241632A1 (hu) |
AT (1) | ATE78161T1 (hu) |
AU (1) | AU611757B2 (hu) |
DE (1) | DE68902056T2 (hu) |
DK (1) | DK169566B1 (hu) |
ES (1) | ES2051898T3 (hu) |
GR (1) | GR3005792T3 (hu) |
HU (1) | HUT49282A (hu) |
IE (1) | IE62426B1 (hu) |
IL (1) | IL89049A0 (hu) |
NZ (1) | NZ227700A (hu) |
PT (1) | PT89561B (hu) |
ZA (1) | ZA89552B (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0448091B1 (en) * | 1990-03-23 | 1998-08-05 | The Green Cross Corporation | Pharmaceutical composition containing slightly water-soluble drug |
CA2548105A1 (en) * | 2003-12-12 | 2005-06-30 | Myogen, Inc. | Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure |
US20060292213A1 (en) * | 2004-06-23 | 2006-12-28 | Myogen, Inc. | Enoximone formulations and their use in the treatment of PDE-III mediated diseases |
EP2581082B1 (de) | 2011-10-10 | 2015-12-30 | Carinopharm GmbH | Pharmazeutische Zusammensetzung zur Behandlung von Status asthmaticus |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405635A (en) * | 1979-06-18 | 1983-09-20 | Merrell Dow Pharmaceuticals Inc. | 4-Aroylimidazol-2-ones and their use as pharmaceuticals |
EP0031603A1 (en) * | 1979-12-31 | 1981-07-08 | American Cyanamid Company | Pharmaceutical composition of matter |
OA06863A (fr) * | 1980-08-04 | 1983-02-28 | Merck & Co Inc | Solubilisation de l'invermectine dans l'eau. |
DE3307422A1 (de) * | 1983-03-03 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen |
EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
-
1989
- 1989-01-24 IL IL89049A patent/IL89049A0/xx unknown
- 1989-01-24 ZA ZA89552A patent/ZA89552B/xx unknown
- 1989-01-24 NZ NZ227700A patent/NZ227700A/xx unknown
- 1989-01-25 AT AT89101268T patent/ATE78161T1/de not_active IP Right Cessation
- 1989-01-25 AU AU28768/89A patent/AU611757B2/en not_active Expired
- 1989-01-25 AR AR89313066A patent/AR241632A1/es active
- 1989-01-25 DE DE8989101268T patent/DE68902056T2/de not_active Expired - Lifetime
- 1989-01-25 EP EP89101268A patent/EP0326103B1/en not_active Expired - Lifetime
- 1989-01-25 ES ES89101268T patent/ES2051898T3/es not_active Expired - Lifetime
- 1989-01-27 DK DK037589A patent/DK169566B1/da not_active IP Right Cessation
- 1989-01-27 IE IE27589A patent/IE62426B1/en not_active IP Right Cessation
- 1989-01-27 PT PT89561A patent/PT89561B/pt not_active IP Right Cessation
- 1989-01-27 HU HU89428A patent/HUT49282A/hu unknown
- 1989-01-27 JP JP1016542A patent/JPH01226817A/ja active Pending
- 1989-01-28 CN CN89100532A patent/CN1035242A/zh active Pending
- 1989-01-28 KR KR1019890000960A patent/KR890011594A/ko not_active Application Discontinuation
-
1992
- 1992-09-24 GR GR920402114T patent/GR3005792T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IE890275L (en) | 1989-07-29 |
KR890011594A (ko) | 1989-08-21 |
ATE78161T1 (de) | 1992-08-15 |
IL89049A0 (en) | 1989-08-15 |
AR241632A1 (es) | 1992-10-30 |
JPH01226817A (ja) | 1989-09-11 |
CN1035242A (zh) | 1989-09-06 |
DK37589D0 (da) | 1989-01-27 |
ES2051898T3 (es) | 1994-07-01 |
AU2876889A (en) | 1989-08-03 |
GR3005792T3 (hu) | 1993-06-07 |
AU611757B2 (en) | 1991-06-20 |
PT89561A (pt) | 1989-10-04 |
NZ227700A (en) | 1990-09-26 |
ZA89552B (en) | 1989-10-25 |
HUT49282A (en) | 1989-09-28 |
DK37589A (da) | 1989-07-30 |
DE68902056T2 (de) | 1992-12-03 |
IE62426B1 (en) | 1995-02-08 |
DE68902056D1 (de) | 1992-08-20 |
PT89561B (pt) | 1994-01-31 |
EP0326103A1 (en) | 1989-08-02 |
EP0326103B1 (en) | 1992-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI490216B (zh) | 用作c型肝炎病毒蛋白酶抑制劑之醫藥組合物 | |
JP3667778B2 (ja) | スフェロイド製剤 | |
JP3678745B2 (ja) | 高濃度アセトアミノフェン溶液含有ゼラチンカプセル | |
EP1207872B1 (en) | Ibuprofen-containing softgels | |
US20110086844A1 (en) | Oral Solid Solution Formulation of a Poorly Water-Soluble Active Substance | |
US6221391B1 (en) | Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith | |
JPH0667829B2 (ja) | イブプロフエン含有ゼラチン軟カプセルおよびその製造方法 | |
EP0277459A2 (de) | Arzneimittel mit verzögerter Wirkstofffreisetzung | |
WO1995031979A1 (en) | Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions | |
EP0706380B1 (en) | Encapsulated medicine | |
DK169566B1 (da) | Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet | |
US20020025338A1 (en) | Bioavailable dosage form of isotrentinoin | |
US6352718B1 (en) | Vasopressin antagonist formulation and process | |
WO2004062692A1 (en) | Formulation of poorly water-soluble active substances | |
JP2009501796A (ja) | 睡眠薬の放出調整 | |
EP3854384A1 (en) | Pharmaceutical formulation comprising abiraterone acetate | |
KR20020039354A (ko) | 바소프레신 길항제 제형 및 방법 | |
AU2002240206B2 (en) | Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle | |
AU2002240206A1 (en) | Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle | |
WO2002013789A1 (en) | Pharmaceutical composition containing 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl] -1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine] | |
MXPA06005247A (es) | Composicion farmaceutica destinada a la administracion oral de un derivado de pirazol-3-carboxamida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |
Country of ref document: DK |